Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Sano Genetics. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sano Genetics or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

EP 196: A new vision for sequencing: In-sample multiomics and precision medicine with Molly He

47:02
 
Share
 

Manage episode 494936219 series 2631947
Content provided by Sano Genetics. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sano Genetics or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

This week on The Genetics Podcast, Patrick is joined by Molly He, CEO and co-founder of Element Biosciences. They discuss the current landscape of sequencing technologies, Element’s innovative sequencing platform, and the potential of using in-sample multiomic profiling across different stages of drug discovery.

Show Notes:

0:00 Intro to The Genetics Podcast

00:59 Welcome to Molly

01:42 Persistent barriers in precision medicine

04:54 Limitations of multiomics technologies and the unique advantage of Element’s approach

07:33 How Element started by inventing an ambitious sequencing instrument

11:33 Overview of the chemistry behind Element’s sequencing technology

14:41 Sequencing workflow of Element’s technology and technical advantages

18:24 Sequencing inside cells and drug discovery insights from a study on tyrosine kinase inhibitor (TKI) resistance pathways

25:57 Sequencing for CRISPR perturbation and direct genotype–phenotype linkage in the same cell

27:33 Whole-transcriptome in situ sequencing and applications in patient samples

29:19 Simplifying single-cell transcriptomics with direct in-sample sequencing

30:31 Applying the single-cell spatial technology to different steps of the drug discovery process

36:43 Competition in the sequencing industry and recent news about Illumina filing a patent infringement case against Element

38:43 Lessons from building Element over eight years

40:32 Insight into maintaining a cohesive culture as Element has multiplied in size and across countries

42:06 The importance of input data quality for AI applications and excitement about the possibility of predicting biology

45:40 Closing remarks

Find out more

Please consider rating and reviewing us on your chosen podcast listening platform!

https://drive.google.com/file/d/1Bp2_wVNSzntTs_zuoizU8bX1dvao4jfj/view?usp=share_link

  continue reading

206 episodes

Artwork
iconShare
 
Manage episode 494936219 series 2631947
Content provided by Sano Genetics. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sano Genetics or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

This week on The Genetics Podcast, Patrick is joined by Molly He, CEO and co-founder of Element Biosciences. They discuss the current landscape of sequencing technologies, Element’s innovative sequencing platform, and the potential of using in-sample multiomic profiling across different stages of drug discovery.

Show Notes:

0:00 Intro to The Genetics Podcast

00:59 Welcome to Molly

01:42 Persistent barriers in precision medicine

04:54 Limitations of multiomics technologies and the unique advantage of Element’s approach

07:33 How Element started by inventing an ambitious sequencing instrument

11:33 Overview of the chemistry behind Element’s sequencing technology

14:41 Sequencing workflow of Element’s technology and technical advantages

18:24 Sequencing inside cells and drug discovery insights from a study on tyrosine kinase inhibitor (TKI) resistance pathways

25:57 Sequencing for CRISPR perturbation and direct genotype–phenotype linkage in the same cell

27:33 Whole-transcriptome in situ sequencing and applications in patient samples

29:19 Simplifying single-cell transcriptomics with direct in-sample sequencing

30:31 Applying the single-cell spatial technology to different steps of the drug discovery process

36:43 Competition in the sequencing industry and recent news about Illumina filing a patent infringement case against Element

38:43 Lessons from building Element over eight years

40:32 Insight into maintaining a cohesive culture as Element has multiplied in size and across countries

42:06 The importance of input data quality for AI applications and excitement about the possibility of predicting biology

45:40 Closing remarks

Find out more

Please consider rating and reviewing us on your chosen podcast listening platform!

https://drive.google.com/file/d/1Bp2_wVNSzntTs_zuoizU8bX1dvao4jfj/view?usp=share_link

  continue reading

206 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play